Search Results - karl+wittrup

1 Results

Sort By:

CD38 and BCMA Bispecific Antibody Pretargeted Radioimmunotherapy for Multiple Myeloma and other B Cell Malignancies

Pretargeted radioimmunotherapy for the treatment of Multiple Myeloma & B cell malignanciesAnti-CD38 and anti-BCMA bispecific antibodies deliver targeted radioimmunotherapy and avoid systemic toxicity. Pretargeted radioimmunotherapy (PRIT) differs from conventional RIT in that a nonradioactive bispecific targeting antibody is first administered allowing...

Published: 11/15/2023 | Updated: 8/20/2018 | Inventor(s): Damian Green, Yukang Lin, Oliver Press, Alice Tzeng, Karl Wittrup

Keywords(s): Hybridoma / Antibody, Immuno Oncology, Target

Category(s): Therapeutic